223 related articles for article (PubMed ID: 33348839)
1. Plasma Inflammatory Biomarkers Associated with Advanced Liver Fibrosis in HIV-HCV-Coinfected Individuals.
Chen X; Liu X; Duan S; Tang R; Zhou S; Ye R; Yang Y; Wang J; Yao S; He N
Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33348839
[TBL] [Abstract][Full Text] [Related]
2. Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.
Mascia C; Lichtner M; Zuccalà P; Vita S; Tieghi T; Marocco R; Savinelli S; Rossi R; Iannetta M; Campagna M; Schiavone F; Mengoni F; Russo G; Mastroianni CM; Vullo V
Clin Res Hepatol Gastroenterol; 2017 Dec; 41(6):644-655. PubMed ID: 28578937
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants upstream of TNFAIP3 in the 6q23 region are associated with liver disease severity in HIV/HCV-coinfected patients: A cross-sectional study.
Jiménez-Sousa MA; Berenguer J; Fernández-Rodríguez A; Medrano LM; Aldámiz-Echevarria T; Pérez-Latorre L; Díez C; Martín-Vicente M; Gutiérrez-Rivas M; Martínez I; Resino S
Infect Genet Evol; 2019 Jan; 67():112-120. PubMed ID: 30336268
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems.
Fuster D; Tsui JI; Cheng DM; Quinn EK; Armah KA; Nunes D; Freiberg MS; Samet JH
AIDS Res Hum Retroviruses; 2013 Aug; 29(8):1110-6. PubMed ID: 23601055
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of liver enzymes and inflammatory biomarkers for the severity of liver fibrosis stage in HIV/HCV co-infected patients.
Charpentier C; Champenois K; Gervais A; Landman R; Joly V; Le Gac S; Larrouy L; Damond F; Brun-Vézinet F; Descamps D; Yazdanpanah Y
PLoS One; 2013; 8(3):e59205. PubMed ID: 23527135
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals.
Griesbeck M; Valantin MA; Lacombe K; Samri-Hassimi A; Bottero J; Blanc C; Sbihi Z; Zoorob R; Katlama C; Guiguet M; Altfeld M; Autran B;
AIDS; 2017 Jun; 31(9):1223-1234. PubMed ID: 28492391
[TBL] [Abstract][Full Text] [Related]
7. HIV Infection, HCV Coinfection, and Alcohol Use: Associations with Microbial Translocation and Immune Activation.
Monnig MA; Cohen R; Ramratnam B; McAdams M; Tashima K; Monti PM
Alcohol Clin Exp Res; 2019 Jun; 43(6):1126-1134. PubMed ID: 30908642
[TBL] [Abstract][Full Text] [Related]
8. Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients.
Medrano LM; Garcia-Broncano P; Berenguer J; González-García J; Jiménez-Sousa MÁ; Guardiola JM; Crespo M; Quereda C; Sanz J; Canorea I; Carrero A; Hontañón V; Muñoz-Fernández MÁ; Resino S;
AIDS; 2018 Jun; 32(9):1095-1105. PubMed ID: 29438197
[TBL] [Abstract][Full Text] [Related]
9. Changes in biomarkers of liver disease during successful combination antiretroviral therapy in HIV-HCV-coinfected individuals.
Rohrbach J; Stickel F; Schmid P; Thormann W; Kovari H; Scherrer A; Günthard HF; Vuichard D; Cavassini M; Ambrosioni J; Bernasconi E; Furrer H; Rauch A;
Antivir Ther; 2014; 19(2):149-59. PubMed ID: 24036684
[TBL] [Abstract][Full Text] [Related]
10. Combination Antiretroviral Therapy Is Associated With Reduction in Liver Fibrosis Scores in HIV-1-Infected Subjects.
Li Y; Xie J; Han Y; Wang H; Lv W; Guo F; Qiu Z; Li Y; Du S; Song X; Zhu T; Thio CL; Li T
Medicine (Baltimore); 2016 Feb; 95(5):e2660. PubMed ID: 26844493
[TBL] [Abstract][Full Text] [Related]
11. Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus.
Reid M; Ma Y; Scherzer R; Price JC; French AL; Huhn GD; Plankey MW; Peters M; Grunfeld C; Tien PC
J Infect Dis; 2018 Mar; 217(8):1289-1297. PubMed ID: 29304196
[TBL] [Abstract][Full Text] [Related]
12. Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients.
Lim JK; Tate JP; Fultz SL; Goulet JL; Conigliaro J; Bryant KJ; Gordon AJ; Gibert C; Rimland D; Goetz MB; Klein MB; Fiellin DA; Justice AC; Lo Re V
Clin Infect Dis; 2014 May; 58(10):1449-58. PubMed ID: 24569533
[TBL] [Abstract][Full Text] [Related]
13. Microbial translocation is associated with advanced liver fibrosis among people with HIV.
He J; Shi R; Duan S; Ye R; Yang Y; Wang J; Zu Z; Tang R; Gao J; Liu X; He N
HIV Med; 2022 Oct; 23(9):947-958. PubMed ID: 35301782
[TBL] [Abstract][Full Text] [Related]
14. Biochemical non-invasive assessment of liver fibrosis cannot replace biopsy in HIV-HCV coinfected patients.
Kliemann DA; Wolff FH; Tovo CV; Alencastro PR; Ikeda ML; Brandão AB; Barcellos N; Fuchs SC
Ann Hepatol; 2016; 15(1):27-32. PubMed ID: 26626637
[TBL] [Abstract][Full Text] [Related]
15. The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study.
Keating SM; Dodge JL; Norris PJ; Heitman J; Gange SJ; French AL; Glesby MJ; Edlin BR; Latham PS; Villacres MC; Greenblatt RM; Peters MG;
PLoS One; 2017; 12(9):e0181004. PubMed ID: 28902848
[TBL] [Abstract][Full Text] [Related]
16. High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262).
Nguyen Truong T; Laureillard D; Lacombe K; Duong Thi H; Pham Thi Hanh P; Truong Thi Xuan L; Chu Thi N; Luong Que A; Vu Hai V; Nagot N; Tuaillon E; Dominguez S; Lemoine M
PLoS One; 2016; 11(5):e0153744. PubMed ID: 27148964
[TBL] [Abstract][Full Text] [Related]
17. A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection.
Hodowanec AC; Lee RD; Brady KE; Gao W; Kincaid S; Plants J; Bahk M; Mackman N; Landay AL; Huhn GD
BMC Infect Dis; 2015 Apr; 15():190. PubMed ID: 25884329
[TBL] [Abstract][Full Text] [Related]
18. Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus.
French AL; Evans CT; Agniel DM; Cohen MH; Peters M; Landay AL; Desai SN
J Infect Dis; 2013 Aug; 208(4):679-89. PubMed ID: 23687224
[TBL] [Abstract][Full Text] [Related]
19. HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection.
Lamoury FM; Hajarizadeh B; Keoshkerian E; Feld JJ; Amin J; Teutsch S; Matthews GV; Hellard M; Dore GJ; Lloyd AR; Applegate TL; Grebely J;
BMC Infect Dis; 2016 Jun; 16():241. PubMed ID: 27246604
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and predictors of liver disease in HIV-infected children and adolescents.
Pokorska-Śpiewak M; Stańska-Perka A; Popielska J; Ołdakowska A; Coupland U; Zawadka K; Szczepańska-Putz M; Marczyńska M
Sci Rep; 2017 Sep; 7(1):12309. PubMed ID: 28951598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
